SCHEMBL6208037

SCHEMBL6208037

Cc1c(C(=O)O)c[nH]c(=O)c1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.52
CSNK2A1 P68400 4/20 0.47
CSNK2A2 P19784 3/20 0.47
CSNK2B P67870 3/20 0.47
KDM4E B2RXH2 2/20 0.47
KDM3B Q7LBC6 1/20 0.43
NOTUM Q6P988 2/20 0.41
F7 P08709 1/20 0.40
F3 P13726 1/20 0.40
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PIM3 Q86V86 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
PRKAB2 O43741 1/20 0.38
PRKAG1 P54619 1/20 0.38
PRKAA2 P54646 1/20 0.38
PRKAA1 Q13131 1/20 0.38
PRKAG3 Q9UGI9 1/20 0.38
PRKAG2 Q9UGJ0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6207236 0.77 DYRK1A (0.47) DYRK1ACSNK2A1CSNK2A2CSNK2BKDM4E
SCHEMBL6207480 0.74 KDM4E (0.44) DYRK1ACSNK2A1CSNK2A2CSNK2BKDM4E
SCHEMBL26708623 0.73 DYRK1A (0.52) DYRK1ACSNK2A1CSNK2A2CSNK2BKDM4E
SCHEMBL547358 0.73 NOTUM (0.50) DYRK1ACSNK2A1CSNK2A2CSNK2BKDM4E
SCHEMBL6023948 0.71 NOTUM (0.46) DYRK1ACSNK2A1CSNK2A2CSNK2BKDM4E
SCHEMBL6208722 0.70 KDM4E (0.44) DYRK1ACSNK2A1CSNK2A2CSNK2BKDM4E
SCHEMBL28944544 0.69 NOTUM (0.50) DYRK1ACSNK2A1CSNK2A2CSNK2BKDM4E
SCHEMBL16654409 0.69 DAO (0.33) DYRK1ADAO
SCHEMBL4784733 0.68 KDM4E (0.39) DYRK1ACSNK2A1CSNK2A2CSNK2BKDM4E
SCHEMBL16918346 0.68 DYRK1A (0.60) DYRK1ACSNK2A1CSNK2A2CSNK2BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546133-A2 N-SUBSTITUTE-2-OXODIHYDROPYRIDINE DERIVATIVES AS NPY ANTAGONISTS BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-06-29 EP disclosed
WO-2004031175-A2 N-SUBSTITUTED-2-OXODIHYDROPYRIDINE DERIVATIVES AS NPY ANTAGONISTS BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-04-15 WO disclosed